
Leslie A. Royds Draper
Examiner (ID: 16913, Phone: (571)272-6096 , Office: P/1629 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1614, 1629 |
| Total Applications | 1232 |
| Issued Applications | 248 |
| Pending Applications | 177 |
| Abandoned Applications | 822 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18018980
[patent_doc_number] => 20220370479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => METHOD AND COMPOSITIONS FOR FORMING A COPPER-CONTAINING COMPLEX AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/866724
[patent_app_country] => US
[patent_app_date] => 2022-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21354
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17866724
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/866724 | Method and compositions for forming a copper-containing complex and uses thereof | Jul 17, 2022 | Issued |
Array
(
[id] => 18273682
[patent_doc_number] => 11612603
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-03-28
[patent_title] => 3-triazolyl methyl-1,3,5-triazine-2,4-dione compounds and preparation method and application thereof
[patent_app_type] => utility
[patent_app_number] => 17/866514
[patent_app_country] => US
[patent_app_date] => 2022-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5698
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17866514
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/866514 | 3-triazolyl methyl-1,3,5-triazine-2,4-dione compounds and preparation method and application thereof | Jul 16, 2022 | Issued |
Array
(
[id] => 18208056
[patent_doc_number] => 20230054313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => ANTITHROMBOTIC COMPOSITIONS AND METHODS FOR USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/866437
[patent_app_country] => US
[patent_app_date] => 2022-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14240
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17866437
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/866437 | Antithrombotic compositions and methods for using same | Jul 14, 2022 | Issued |
Array
(
[id] => 18012080
[patent_doc_number] => 11504354
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-11-22
[patent_title] => Chlorinated tetralin compounds and pharmaceutical compositions
[patent_app_type] => utility
[patent_app_number] => 17/860682
[patent_app_country] => US
[patent_app_date] => 2022-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13791
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17860682
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/860682 | Chlorinated tetralin compounds and pharmaceutical compositions | Jul 7, 2022 | Issued |
Array
(
[id] => 18815959
[patent_doc_number] => 20230390298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => METHOD AND COMPOSITIONS FOR USE IN PROVIDING MALE CONTRACEPTION
[patent_app_type] => utility
[patent_app_number] => 17/833131
[patent_app_country] => US
[patent_app_date] => 2022-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6729
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17833131
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/833131 | METHOD AND COMPOSITIONS FOR USE IN PROVIDING MALE CONTRACEPTION | Jun 5, 2022 | Abandoned |
Array
(
[id] => 17881114
[patent_doc_number] => 20220296591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => ORGANIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/832282
[patent_app_country] => US
[patent_app_date] => 2022-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24442
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17832282
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/832282 | ORGANIC COMPOUNDS | Jun 2, 2022 | Pending |
Array
(
[id] => 17958545
[patent_doc_number] => 20220339125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => MITORIBOSCINS: MITOCHONDRIAL-BASED THERAPEUTICS TARGETING CANCER CELLS, BACTERIA, AND PATHOGENIC YEAST
[patent_app_type] => utility
[patent_app_number] => 17/748354
[patent_app_country] => US
[patent_app_date] => 2022-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8209
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17748354
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/748354 | MITORIBOSCINS: MITOCHONDRIAL-BASED THERAPEUTICS TARGETING CANCER CELLS, BACTERIA, AND PATHOGENIC YEAST | May 18, 2022 | Pending |
Array
(
[id] => 18139791
[patent_doc_number] => 20230013627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => THIAZOLIDINEDIONE ANALOGS FOR THE TREATMENT OF NAFLD AND METABOLIC DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/738974
[patent_app_country] => US
[patent_app_date] => 2022-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50557
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17738974
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/738974 | THIAZOLIDINEDIONE ANALOGS FOR THE TREATMENT OF NAFLD AND METABOLIC DISEASES | May 5, 2022 | Pending |
Array
(
[id] => 18197165
[patent_doc_number] => 20230050684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => USE OF POTASSIUM CHANNEL INHIBITOR FOR TREATING DEPRESSION
[patent_app_type] => utility
[patent_app_number] => 17/717140
[patent_app_country] => US
[patent_app_date] => 2022-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12071
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17717140
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/717140 | USE OF POTASSIUM CHANNEL INHIBITOR FOR TREATING DEPRESSION | Apr 10, 2022 | Abandoned |
Array
(
[id] => 18147473
[patent_doc_number] => 20230021330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => TOPICAL FORMULATIONS OF 5-ALPHA-REDUCTASE INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/709710
[patent_app_country] => US
[patent_app_date] => 2022-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10607
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17709710
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/709710 | TOPICAL FORMULATIONS OF 5-ALPHA-REDUCTASE INHIBITORS AND USES THEREOF | Mar 30, 2022 | Pending |
Array
(
[id] => 17670835
[patent_doc_number] => 20220184002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => TOPICAL DAPSONE AND DAPSONE/ADAPALENE COMPOSITIONS AND METHODS FOR USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/654061
[patent_app_country] => US
[patent_app_date] => 2022-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5481
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17654061
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/654061 | TOPICAL DAPSONE AND DAPSONE/ADAPALENE COMPOSITIONS AND METHODS FOR USE THEREOF | Mar 7, 2022 | Abandoned |
Array
(
[id] => 17670908
[patent_doc_number] => 20220184075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => PHARMACEUTICAL COMPOSITION CONTAINING HDAC6 INHIBITOR AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF ITCHING
[patent_app_type] => utility
[patent_app_number] => 17/687929
[patent_app_country] => US
[patent_app_date] => 2022-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2834
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17687929
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/687929 | PHARMACEUTICAL COMPOSITION CONTAINING HDAC6 INHIBITOR AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF ITCHING | Mar 6, 2022 | Abandoned |
Array
(
[id] => 17850405
[patent_doc_number] => 20220280446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => STABLE CANNABINOID FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/675805
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16181
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17675805
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/675805 | STABLE CANNABINOID FORMULATIONS | Feb 17, 2022 | Pending |
Array
(
[id] => 17640580
[patent_doc_number] => 20220168318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATMENT OF INSOMNIA
[patent_app_type] => utility
[patent_app_number] => 17/673136
[patent_app_country] => US
[patent_app_date] => 2022-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5171
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17673136
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/673136 | Pharmaceutical compositions and methods for treatment of insomnia | Feb 15, 2022 | Issued |
Array
(
[id] => 17609674
[patent_doc_number] => 20220151953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => TREATMENT OF INFLAMMATORY SKIN CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/587543
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3158
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17587543
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/587543 | TREATMENT OF INFLAMMATORY SKIN CONDITIONS | Jan 27, 2022 | Abandoned |
Array
(
[id] => 17593370
[patent_doc_number] => 20220142943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => Method of Producing Cannabidiol Derived Products
[patent_app_type] => utility
[patent_app_number] => 17/579920
[patent_app_country] => US
[patent_app_date] => 2022-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7025
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17579920
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/579920 | Method of Producing Cannabidiol Derived Products | Jan 19, 2022 | Pending |
Array
(
[id] => 17733181
[patent_doc_number] => 20220218640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => AMINO ACID DELIVERY SYSTEM
[patent_app_type] => utility
[patent_app_number] => 17/572368
[patent_app_country] => US
[patent_app_date] => 2022-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2226
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17572368
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/572368 | AMINO ACID DELIVERY SYSTEM | Jan 9, 2022 | Abandoned |
Array
(
[id] => 18777820
[patent_doc_number] => 11819495
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-21
[patent_title] => Compositions and methods for treating severe constipation
[patent_app_type] => utility
[patent_app_number] => 17/565584
[patent_app_country] => US
[patent_app_date] => 2021-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3123
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17565584
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/565584 | Compositions and methods for treating severe constipation | Dec 29, 2021 | Issued |
Array
(
[id] => 17996659
[patent_doc_number] => 11497745
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-15
[patent_title] => Methods for treating cholestasis
[patent_app_type] => utility
[patent_app_number] => 17/554588
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 55
[patent_no_of_words] => 52936
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17554588
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/554588 | Methods for treating cholestasis | Dec 16, 2021 | Issued |
Array
(
[id] => 17503389
[patent_doc_number] => 20220096491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE AND PARKINSON'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/546342
[patent_app_country] => US
[patent_app_date] => 2021-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5727
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17546342
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/546342 | COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE AND PARKINSON'S DISEASE | Dec 8, 2021 | Pending |